ReviewClinics in chest medicine2015
The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis.
Review in Clinics in chest medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 59 citations in OpenAlex.
- Article
- Pathogenetic Mechanisms Linking Sarcoidosis to Lymphoma.International journal of molecular sciences · 2025Review
- Comparison between diffuse and partial involvement of thoracic lymph nodes on the outcome of sarcoidosis patients.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024Article
- Sarcoidosis following COVID infection: A case series.Respirology case reports · 2023Article
- Genetics of neurosarcoidosis.Journal of neuroimmunology · 2022Review
- Article
- Sarcoidosis following SARS-CoV-2 infection: Cause or consequence?Respirology case reports · 2022Article
- Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?Autoimmunity reviews · 2021Article
- CD31Journal of thoracic disease · 2021Article
- Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives.Diagnostics (Basel, Switzerland) · 2021Review
- Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia.JAAD case reports · 2020Article
- Current Sarcoidosis Models and the Importance of Focusing on the Granuloma.Frontiers in immunology · 2020Review
- Trained Innate Immunity Not Always Amicable.International journal of molecular sciences · 2019Review
- The composition of the pulmonary microbiota in sarcoidosis - an observational study.Respiratory research · 2019Observational
- Sarcoidosis in A. C. Milan (1899)?Open access Macedonian journal of medical sciences · 2018Article
- Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis.PloS one · 2018Article
- High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis.Respiratory research · 2017Article
- The presence of mycobacterial antigens in sarcoidosis associated granulomas.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2017Article
- ATS Core Curriculum 2016. Part IV. Adult Pulmonary Medicine Core Curriculum.Annals of the American Thoracic Society · 2016Article
- Cutaneous Sarcoidosis in Corona Virus Disease 19 Patient: A Red Herring or Sign of Recovery?Indian dermatology online journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Sarcoidosis is a granulomatous disease of unknown etiology, most commonly involving the lung, skin, lymph node, and eyes. Molecular and immunologic studies continue to strengthen the association of sarcoidosis with infectious antigens. Independent studies report the presence of microbial nucleic acids and proteins within sarcoidosis specimens. Complementary immunologic studies also support the role of infectious agents in sarcoidosis pathogenesis. Case reports and clinical trials have emerged regarding the efficacy of antimicrobials. They support increasing efforts to identify novel therapeutics, such as antimicrobials, that will have an impact on the observed increase in sarcoidosis morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.